Amphasys
Amphasys AG, founded 2012 in Lucerne, Switzerland, develops impedance flow cytometry instruments for label-free single-cell analysis, serving plant breeding and seed production enterprises as well as bioprocessing and food technology customers with hardware, consumable chips, and software.
- Company typePrivate
- Founded2012
- HeadquartersLucerne, Switzerland
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Amphasys does
Amphasys AG is a Swiss specialty instrument company, founded in 2012 and headquartered at Technopark Lucerne, that develops and manufactures impedance flow cytometry (IFC) platforms for label-free, real-time single-cell analysis. Its core technology characterizes cells as they pass through microfluidic channels under alternating electrical fields, measuring cell size, membrane integrity, cytoplasmic conductivity, and metabolic status without dyes, markers, or calibration. The product line consists of three analyzers — the Ampha Z40 (stationary instrument for pollen and cells larger than 50 μm), the Ampha X30 (stationary instrument optimized for 1–50 μm cells in bioprocessing), and the Ampha P20 (portable battery-powered field analyzer) — supported by AmphaSoft PRO analysis software, patented microfluidic consumable chips (universal and crop-specific variants covering 250+ plant species), and AmphaFluid buffer solutions.
The company sells primarily to enterprise customers in the plant breeding and seed production industry (BASF, Bayer, Corteva, Syngenta, Rijk Zwaan, KWS, Bejo, Enza Zaden, Lidea Seeds, PanAmerican Seed), with growing penetration into industrial bioprocessing and food technology applications (Nestlé, Bühler, Doppelleu, Planet A Foods, edete Precision Technologies, Dropcopter) and academic research (University of Salzburg, University of Virginia, EPFL, RWTH Aachen). Revenue is generated through a mix of hardware sales, recurring consumable chip revenue, software, and service contracts, distributed via direct enterprise sales complemented by a global regional distributor network across Europe, North America, South America, Australia, and Africa.
Pricing is quote-based rather than publicly disclosed, consistent with enterprise sales of capital equipment plus multi-year service agreements. The company holds ISO 9001:2015 certification, supports 21 CFR Part 11-compliant workflows on the Ampha X30, and maintains community engagement through its annual Amphacademy symposium, which has run annually since 2017. No external equity funding rounds are disclosed, with only non-dilutive participation in MassChallenge (2020) and Technopark Luzern (2017) recorded, indicating an organic, self-funded growth profile across roughly 13 years of operation.
Amphasys firmographics
Firmographics- Name
- Amphasys
- Legal name
- Amphasys AG
- Website
- https://amphasys.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Amphasys AG, founded 2012 in Lucerne, Switzerland, develops impedance flow cytometry instruments for label-free single-cell analysis, serving plant breeding and seed production enterprises as well as bioprocessing and food technology customers with hardware, consumable chips, and software.
- Ownership category
- akta.pro rank
Amphasys industry classification
Industry- Product category
- Analytical Laboratory Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industries
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Single-Use Technologies (SUT) & Disposable Fluid Management (bags, assemblies, connectors) (HLAAAJAC)
Keywords
Where Amphasys is headquartered
LocationHeadquarters
- HQ city
- Lucerne
- HQ country
- Switzerland
- HQ region
- Europe
Offices1 record
Markets served
Amphasys business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Hardware Sales - Impedance Flow Cytometers: Sale of Ampha X30, Ampha Z40, and Ampha P20 instruments - the core impedance flow cytometry hardware platforms for cell and pollen analysis.
- Microfluidic Chips (AmphaChip): Recurring consumable revenue from universal and crop-specific microfluidic chips. Universal chips come in 4 sizes; crop-specific chips available for major crops. Each chip provides 1000 measurements.
- Software Licenses and Subscriptions: AmphaSoft PRO software for data analysis. The software is integrated with the instrument platform and supports both automated routine analysis and in-depth research analysis.
- Support and Maintenance Contracts: Annual support and maintenance plans for instruments including software updates, technical support, and calibration services. Separate service contracts available for Ampha P20 and Ampha Z32/Z40 instruments.
- Buffer Solutions and Consumables: AmphaFluid buffer solutions (AF3 through AF11) and other consumables including AmphaCount and AmphaCalib for measurement preparation and calibration.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Custom enterprise pricing based on instrument configuration and support package |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels7 records
Amphasys product offering
Product offeringCore offering
Amphasys develops and manufactures impedance flow cytometry instruments and consumables for label-free, real-time single-cell analysis. Its product portfolio includes the Ampha Z40 (universal lab analyzer for pollen and cells >50μm), Ampha P20 (portable field pollen analyzer), and Ampha X30 (bioprocessing analyzer for cells 1–50μm), complemented by AmphaSoft PRO software, AmphaChip microfluidic consumables, and AmphaFluid buffer solutions.
Product overview
Amphasys offers a portfolio of impedance flow cytometry instruments for label-free single-cell analysis in the seed industry and bioprocessing. The product line centers on three main instruments: Ampha Z40 (universal laboratory analyzer for pollen and cells >50μm), Ampha P20 (portable field analyzer for on-site pollen testing), and Ampha X30 (bioprocessing analyzer for cells 1-50μm including yeast, bacteria, and mammalian cells). These instruments share the same underlying impedance flow cytometry technology platform and are supported by AmphaSoft PRO software for data analysis, AmphaChip microfluidic consumables (available as universal chips for all pollen types or crop-specific chips with automated protocols), and AmphaFluid buffer solutions. The ecosystem is designed for applications ranging from plant breeding and seed production to bioprocess monitoring and quality control.
Differentiator
Problem solved
Functional benefit
Products and services
- Ampha Z40 Universal, flexible laboratory instrument for impedance-based cell analysis, specifically designed for cells larger than 50 μm such as pollen. Combines advanced cell viability research capabilities with high-throughput routine analysis for plant research, breeding, and seed production applications.
- Ampha P20 Portable pollen analyzer providing laboratory-grade pollen viability and quantity measurements directly to the greenhouse, field, or production site. Compact, rugged, battery-powered design with touchscreen interface and automated data analysis for on-site decision-making.
- Ampha X30 Stationary cell analyzer tailored for bioprocessing workflows, optimized for cells from 1 to 50 μm including yeast, bacteria, and mammalian cells. Provides real-time, label-free insights into cell viability, concentration, and metabolic activity even in turbid or complex media.
- AmphaSoft PRO Integrated software environment for structured pollen data evaluation, converting electrical impedance signals into interpretable scatterplots. Enables both fully automated data analysis and detailed individual interpretation with standardized evaluation settings.
- AmphaChip (Universal) Universal microfluidic chips available in four channel sizes (80, 120, 250, 300 μm) compatible with Ampha Z40, providing full flexibility for research applications, user-defined gating strategies, and custom sampling protocols for analyzing pollen from all plants.
- AmphaChip (Crop-Specific) Crop-specific microfluidic chips for automated pollen analysis, available for major crops including tomato, pepper, brassicas, cucurbits, corn, wheat, sunflower, onion, carrot, and beet. Predefined measurement parameters and automated data analysis without gating strategies required.
- AmphaFluid Series Buffer solutions (AmphaFluid 3 through 11) for pollen sample preparation and measurement. Each formulation optimized for specific pollen types and measurement conditions.
Quantifiable outcome
- 9000 pollen viability measurements per year conducted at a single tomato seed production site
- +4 more outcomes
Companies that use Amphasys
Customer profileNamed customers14 records
Segments3 records
Ideal customer profiles3 records
Amphasys technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Amphasys partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- DropcoptercoreUS-based drone technology company offering aerial pollination services to farmers. Uses Ampha Z32 for pollen quality control to ensure the right pollen is applied at the right time and place. Partnership enables supplementary pollination for fruit orchards using drone technology combined with Amphasys' pollen analysis.
- Planet A FoodscoreDeveloped ChoViva, a sustainable chocolate alternative, and ChoViva butter through precision fermentation of oleaginous yeasts. Uses Amphasys impedance flow cytometry technology to optimize fermentation processes, achieving cocoa butter alternative that is 90% chemically identical to cocoa butter with over 90% reduction in greenhouse gas emissions and water usage.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Amphasys competitors and assessment
Company assessmentBroad incumbents
- Beckman Coulter Life Sciences (Danaher): Global flow cytometry leader with the CytoFLEX, Navios, and Gallios platforms serving pharma, biotech, and academic customers. Amphasys competes in adjacent flow cytometry workflows but lacks the broad menu and global service network.
- BD Biosciences: One of the two dominant flow cytometry players, with the BD FACSDiscover, LSRFortessa, and cell sorting portfolios. Comparable in product category (single-cell analysis instruments) but vastly broader in customer base and reagents.
- Agilent Technologies (Cell Analysis): Provides the Seahorse metabolic analysis platform and cell analysis flow cytometry tools for pharma and biotech. Overlaps with Amphasys' bioprocess metabolic-status positioning, with much broader portfolio reach.
- Sysmex Partec: Flow cytometry instruments and reagents for clinical and research markets. Offers competing cell analysis platforms with broader menus, comparable in product category though different in target segments.
Direct peers
- Cytek Biosciences: Specialist flow cytometry company known for the Aurora spectral cell analyzer. Targets immunology, oncology, and bioprocess workflows with a more comprehensive cell analysis platform than Amphasys, but shares a similar instrument-sale + consumable economics.
- Apogee Flow Systems: Specialist in flow cytometry for sub-micron particles including bacteria, mitochondria, and viruses. Closest competitor to Amphasys' small-cell bioprocess applications with a comparable scale and product philosophy.
- Chemometec: NucleoCounter line of cell counting and viability instruments used in cell therapy, bioprocess, and quality control. Competes with the Ampha X30 for routine cell counting/viability slots in bioprocess labs.
Emerging players
- NanoCellect Biomedical: Microfluidic cell sorting and analysis tools using gentle, label-free approaches. Shares the microfluidic heritage with Amphasys and targets cell therapy and bioprocess workflows.
- Levitas Bio: Developer of label-free magnetic levitation cell analysis for life science research. Represents a competing label-free single-cell analysis approach that could overlap with impedance-based workflows.
Others
- Sartorius: Major bioprocess equipment and consumables supplier whose customer base (pharma and biotech manufacturers) overlaps directly with Amphasys' bioprocess users. Adjacent rather than directly competitive, but shapes bioprocess procurement decisions.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Amphasys social profiles
Digital presenceAmphasys compliance and trust
Trust signalCompliance2 records
Amphasys financial estimates
Financial estimateRevenue estimate
Valuation estimate
Amphasys leadership team
Management profileNumber of profiles
Profiles9 records
Amphasys funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Amphasys M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Amphasys
What does Amphasys do?
Amphasys develops and manufactures impedance flow cytometry instruments and consumables for label-free, real-time single-cell analysis. Its product portfolio includes the Ampha Z40 (universal lab analyzer for pollen and cells >50μm), Ampha P20 (portable field pollen analyzer), and Ampha X30 (bioprocessing analyzer for cells 1–50μm), complemented by AmphaSoft PRO software, AmphaChip microfluidic consumables, and AmphaFluid buffer solutions.
Is Amphasys a public or private company?
Amphasys is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Amphasys founded?
Amphasys was founded in 2012. It employs 11 to 50 people.
Where is Amphasys based?
Amphasys is headquartered in Lucerne, Switzerland, in the Europe region.
How does Amphasys make money?
Five revenue lines are on record. Hardware Sales - Impedance Flow Cytometers are the primary driver. The others are microfluidic Chips (AmphaChip), software Licenses and Subscriptions, support and Maintenance Contracts and buffer Solutions and Consumables.
Who are Amphasys's main competitors?
Broad incumbents on record are Beckman Coulter Life Sciences (Danaher), BD Biosciences, Agilent Technologies (Cell Analysis) and Sysmex Partec. Direct peers are Cytek Biosciences, Apogee Flow Systems and Chemometec. Emerging players are NanoCellect Biomedical and Levitas Bio. Sartorius is listed as an others.
Does Amphasys have an API?
No public API is recorded for Amphasys.
What industry is Amphasys in?
Amphasys's product category is Analytical Laboratory Instruments. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 334516 and its SIC code is 3826.